|
|
|
| |
|
|
| |
Fluorescent labeling of biomolecules
(immunoassays,
biochips...) is one of the leading applications of semiconductor
nanocrystals. They combine a tunable emission wavelength with a large
absorption spectrum. Their improved stability against photobleaching
compared to organic dyes represents another advantage. We are
working on new methods for the hydrosolubilisation of nanocrystals and
their grafting on proteins or oligonucleotides, and on the use of QDs
in FRET-based
immunoassays.
In recent years also nanotoxicological studies both in vitro and in
vivo have been undertaken, in particular on novel types of QDs like InP.
|
|
|

|
Fluorescence microscopy images
of agarose
beads (mean size: 50µm), labeled with biotinylated nanocrystals (top
row) and with biotinylated R-Phycoerythrin (bottom row). The photos are
taken at the specified time intervals under continuous irradiation with
a mercury lamp. While the fluorescence of the Phycoerythrin labeled
beads is practically extinguished after 15 minutes, the emission of the
nanocrystal labeled ones can still be detected after 8 hours,
demonstrating a significantly higher photostability.
Details
|
|
| |
CuInS2/ZnS
QDs under room light (left), UV light (middle), and
bio-distribution (right) revealed by fluorescence reflectance imaging.
|
|
|
| |

|
InP/ZnS
QDs showing long-term (>
3 months) colloidal stability and
retaining > 90% of the initial fluorescence quantum yield after
aqueous phase transfer with bifunctional thiols under optimized
conditions. These comprise the precise adjusting of pH value of the
aqueous phase containing the new ligand and the use of an appropriate
reducing agent for disulfide bonds, such as
tris(2-carboxyethyl)phosphine, TCEP.
|
|
| |
Main
collaborators:
I. Texier and coll. (CEA Grenoble, DRT/LETI/DTBS)
M. Dahan and coll. (Institut Curie, Paris)
M. De Waard (INSERM Grenoble)
D. Imbert, M. Mazzanti, M. Carriere (CEA Grenoble, INAC/SyMMES)
C. Tortiglione (CNR Pozzuoli)
L. Charbonniere (IPHC Strasbourg)
N.
Hildebrandt (IEF Orsay)
|
|
|
Our
current research focuses on the development of cadmium-free fluorescent
probes for in vivo and in vitro applications.
Funding
from the European Union FP6/FP7 (POC4LIFE), from the French Research
Agency ANR (SYNERGIE, NIRA, NANOFRET, NEUTRINOS) and from CEA is
acknowledged.
|
|
| |
|
|
|
|